➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Express Scripts

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

CLOBETASOL PROPIONATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for clobetasol propionate and what is the scope of patent protection?

Clobetasol propionate is the generic ingredient in twelve branded drugs marketed by Glenmark Pharms Ltd, Ingenus Pharms Llc, Perrigo Israel, Perrigo Uk Finco, Taro, Mylan, Aleor Dermaceuticals, Amneal Pharms Llc, Cosette, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Rising, Teligent Pharma Inc, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Hi Tech Pharma, Encore Dermat, Perrigo Co, Actavis Mid Atlantic, Cadila, Hi Tech, Galderma Labs Lp, Mylan Labs Inc, Encube, Novel Labs Inc, Galderma Labs, Macleods Pharms Ltd, Saptalis Pharms, Tolmar, Wockhardt Bio Ag, Akorn, Apotex, and Paddock Llc, and is included in eighty-eight NDAs. There are seven patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Clobetasol propionate has seventy-six patent family members in twenty-six countries.

There are fourteen drug master file entries for clobetasol propionate. Fifty-two suppliers are listed for this compound.

Drug Prices for CLOBETASOL PROPIONATE

See drug prices for CLOBETASOL PROPIONATE

Drug Sales Revenue Trends for CLOBETASOL PROPIONATE

See drug sales revenues for CLOBETASOL PROPIONATE

Recent Clinical Trials for CLOBETASOL PROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Malmö UniversityPhase 2/Phase 3
Skane University HospitalPhase 2/Phase 3
SalvatPhase 3

See all CLOBETASOL PROPIONATE clinical trials

Pharmacology for CLOBETASOL PROPIONATE
Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE
Paragraph IV (Patent) Challenges for CLOBETASOL PROPIONATE
Tradename Dosage Ingredient NDA Submissiondate
IMPOYZ CREAM;TOPICAL clobetasol propionate 209483 2019-12-06
OLUX E AEROSOL, FOAM;TOPICAL clobetasol propionate 022013 2010-02-25
CLOBEX SPRAY;TOPICAL clobetasol propionate 021835 2008-09-29
CLOBEX SHAMPOO;TOPICAL clobetasol propionate 021644 2008-01-09
CLOBEX LOTION;TOPICAL clobetasol propionate 021535 2006-03-27
OLUX AEROSOL, FOAM;TOPICAL clobetasol propionate 021142 2005-06-27

US Patents and Regulatory Information for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 074139-001 Aug 3, 1994 AB1 RX No No   Start Trial   Start Trial   Start Trial
Cosette CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 074089-001 Feb 16, 1994 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 210208-001 Jan 30, 2018 AB1 RX No No   Start Trial   Start Trial   Start Trial
Aleor Dermaceuticals CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 212881-001 Oct 21, 2019 AT RX No No   Start Trial   Start Trial   Start Trial
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes   Start Trial   Start Trial   Start Trial
Taro CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 075363-001 Dec 29, 2000 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs Lp CLOBEX clobetasol propionate SPRAY;TOPICAL 021835-001 Oct 27, 2005   Start Trial   Start Trial
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990   Start Trial   Start Trial
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985   Start Trial   Start Trial
Mylan OLUX clobetasol propionate AEROSOL, FOAM;TOPICAL 021142-001 May 26, 2000   Start Trial   Start Trial
Galderma Labs Lp CLOBEX clobetasol propionate SPRAY;TOPICAL 021835-001 Oct 27, 2005   Start Trial   Start Trial
Mylan OLUX E clobetasol propionate AEROSOL, FOAM;TOPICAL 022013-001 Jan 12, 2007   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
McKesson
Mallinckrodt
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.